{"blog": [], "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Pearson, John Michael (1959- )", "name": "persons", "rank": "3", "is_major": "Y"}, {"value": "Senate", "name": "organizations", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/03/29/business/valeant-chief-to-testify-before-senate-in-april.html", "document_type": "article", "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "128", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "The disclosure that J. Michael Pearson had been called to testify on Capitol Hill sent Valeant\u2019s shares sharply down.", "pub_date": "2016-03-29T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Valeant\u2019s Chief Asked to Testify", "main": "Valeant Chief to Testify Before Senate in April"}, "print_page": "3", "snippet": "The disclosure that J. Michael Pearson had been called to testify on Capitol Hill sent Valeant\u2019s shares sharply down.", "_id": "56f9b52938f0d874a87cb099", "slideshow_credits": null, "abstract": "Valeant Pharmaceuticals shares fall more than 7 percent on news that chief executive J Michael Pearson will be asked to testify before Senate committee about quick rise in drug prices.  "}